Detection of Viral Particels in Urticaria Patients

Urticaria Chronic Clinical Trial

Official title:

Detection of Viral Particels in Urticaria Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03151902
• Other study ID #: HaEmekMC1
• Status: Recruiting
• Start date: July 2, 2017
• Est. completion date: September 30, 2023

Study information

• Verified date: March 2022
• Source: HaEmek Medical Center, Israel
• Contact: Menachem Rottem, MD
• Phone: +972-528617823
• Email: rottem_me[@]clalit.org.il
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Blood samples from urticaria patients will be analyzed for viral particles

Description:

After digestion with DNase to eliminate human DNA, RNA will be reversed-transcribed and amplified with random primer/ Amplification products will be pooled and sequenced/ After substruction of sequences of vertebrates and highly repetitive sequences, contiguous sequences will be assembled and compared with motifs represented in databases of viruses. which will enable identification of putative protein sequences consistent with viruses

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: September 30, 2023
• Est. primary completion date: December 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with chronic spontaneous urticaria

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Chronic Urticaria
• Urticaria
• Urticaria Chronic

Locations

Country	Name	City	State
Israel	Emek Medical Center	Afula

Sponsors (1)

Lead Sponsor	Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	viral particles	presence of viral particels	6 months